期刊
MOLECULAR NEUROBIOLOGY
卷 45, 期 3, 页码 550-563出版社
SPRINGER
DOI: 10.1007/s12035-012-8274-9
关键词
DNA damage; BRCA1; H2AX; Neurodegeneration; Huntington's disease
资金
- KOSEF [2010-0029-403, 800-20080848]
- NIH [NS 067283-01A1]
- Susan G. Komen Breast Cancer Research Award
- [R01CA79892]
- [R01CA90631]
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder of mid-life onset characterized by involuntary movements and progressive cognitive decline caused by a CAG repeat expansion in exon 1 of the Huntingtin (Htt) gene. Neuronal DNA damage is one of the major features of neurodegeneration in HD, but it is not known how it arises or relates to the triplet repeat expansion mutation in the Htt gene. Herein, we found that imbalanced levels of non-phosphorylated and phosphorylated BRCA1 contribute to the DNA damage response in HD. Notably, nuclear foci of gamma-H2AX, the molecular component that recruits various DNA damage repair factors to damage sites including BRCA1, were deregulated when DNA was damaged in HD cell lines. BRCA1 specifically interacted with gamma-H2AX via the BRCT domain, and this association was reduced in HD. BRCA1 overexpression restored gamma-H2AX level in the nucleus of HD cells, while BRCA1 knockdown reduced the spatiotemporal propagation of gamma-H2AX foci to the nucleoplasm. The deregulation of BRCA1 correlated with an abnormal nuclear distribution of gamma-H2AX in striatal neurons of HD transgenic (R6/2) mice and BRCA1(+/-) mice. Our data indicate that BRCA1 is required for the efficient focal recruitment of gamma-H2AX to the sites of neuronal DNA damage. Taken together, our results show that BRCA1 directly modulates the spatiotemporal dynamics of gamma-H2AX upon genotoxic stress and serves as a molecular maker for neuronal DNA damage response in HD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据